{"AllianceGenome": "5433", "HGNC": "5433", "MIM": "602376", "_id": "3455", "_version": 2, "accession": {"genomic": ["AF039905.1", "AH004970.2", "AP000292.1", "AP000293.1", "AP000294.1", "AP000295.1", "AP001716.1", "AY740397.1", "CH471079.2", "CP068257.2", "KF457225.1", "NC_000021.9", "NC_060945.1", "NG_016003.2"], "protein": ["AAB46413.1", "AAB46414.1", "AAB46415.1", "AAB46417.1", "AAB46418.1", "AAB46419.1", "AAC50202.1", "AAH02793.1", "AAU21038.1", "BAF85748.1", "CAA54785.1", "CAA61914.1", "CAA61940.1", "CAG46616.1", "CDG37809.1", "EAX09842.1", "EAX09843.1", "EAX09844.1", "EAX09845.1", "EAX09846.1", "NP_000865.2", "NP_001276054.1", "NP_001276055.1", "NP_001276057.1", "NP_001371983.1", "NP_001371984.1", "NP_997467.1", "NP_997468.1", "P48551.1"], "rna": ["AK293059.1", "BC002793.2", "BC013156.1", "BG715143.1", "BI520056.1", "BM677386.1", "CD110317.1", "CR541817.1", "HG380509.1", "HY104613.1", "L41942.1", "L41943.1", "L41944.1", "NM_000874.5", "NM_001289125.3", "NM_001289126.2", "NM_001289128.2", "NM_001385054.1", "NM_001385055.1", "NM_207584.3", "NM_207585.3", "U29584.1", "X77722.1", "X89772.1", "X89814.1"], "translation": [{"protein": "AAB46414.1", "rna": "L41943.1"}, {"protein": "CAA61914.1", "rna": "X89772.1"}, {"protein": "AAH02793.1", "rna": "BC002793.2"}, {"protein": "AAC50202.1", "rna": "U29584.1"}, {"protein": "CAG46616.1", "rna": "CR541817.1"}, {"protein": "NP_001371984.1", "rna": "NM_001385055.1"}, {"protein": "BAF85748.1", "rna": "AK293059.1"}, {"protein": "NP_997467.1", "rna": "NM_207584.3"}, {"protein": "NP_001276054.1", "rna": "NM_001289125.3"}, {"protein": "AAB46413.1", "rna": "L41942.1"}, {"protein": "CAA61940.1", "rna": "X89814.1"}, {"protein": "CDG37809.1", "rna": "HG380509.1"}, {"protein": "AAB46415.1", "rna": "L41944.1"}, {"protein": "CAA54785.1", "rna": "X77722.1"}, {"protein": "NP_001276055.1", "rna": "NM_001289126.2"}, {"protein": "NP_997468.1", "rna": "NM_207585.3"}, {"protein": "NP_001371983.1", "rna": "NM_001385054.1"}, {"protein": "NP_000865.2", "rna": "NM_000874.5"}, {"protein": "NP_001276057.1", "rna": "NM_001289128.2"}]}, "alias": ["IFN-R", "IFN-R-2", "IFN-alpha-REC", "IFNABR", "IFNARB", "IMD45"], "ensembl": {"gene": "ENSG00000159110", "protein": ["ENSP00000343289", "ENSP00000343957", "ENSP00000371673", "ENSP00000371699", "ENSP00000384309", "ENSP00000398799", "ENSP00000402311", "ENSP00000403569", "ENSP00000413160", "ENSP00000508013", "ENSP00000508323"], "transcript": ["ENST00000342101", "ENST00000342136", "ENST00000382238", "ENST00000382264", "ENST00000404220", "ENST00000413881", "ENST00000417007", "ENST00000420068", "ENST00000443073", "ENST00000447980", "ENST00000682044", "ENST00000683941", "ENST00000700427", "ENST00000700429"], "translation": [{"protein": "ENSP00000508013", "rna": "ENST00000683941"}, {"protein": "ENSP00000371699", "rna": "ENST00000382264"}, {"protein": "ENSP00000343957", "rna": "ENST00000342136"}, {"protein": "ENSP00000384309", "rna": "ENST00000404220"}, {"protein": "ENSP00000343289", "rna": "ENST00000342101"}, {"protein": "ENSP00000371673", "rna": "ENST00000382238"}, {"protein": "ENSP00000413160", "rna": "ENST00000413881"}, {"protein": "ENSP00000403569", "rna": "ENST00000443073"}, {"protein": "ENSP00000402311", "rna": "ENST00000447980"}, {"protein": "ENSP00000508323", "rna": "ENST00000682044"}, {"protein": "ENSP00000398799", "rna": "ENST00000417007"}], "type_of_gene": "protein_coding"}, "entrezgene": "3455", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 13.6834803615, "exp_mis": 153.544542788, "exp_syn": 76.0838938916, "lof_z": 2.05754524108641, "mis_z": -1.36005943532698, "mu_lof": 9.26921119438e-07, "mu_mis": 1.34315915878e-05, "mu_syn": 6.51602132181e-06, "n_lof": 6.0, "n_mis": 188.0, "n_syn": 75.0, "p_li": 0.00506602558328155, "p_null": 0.0268733443980551, "p_rec": 0.968060630018663, "syn_z": 0.0770350374263116}, "bp": 1548, "cds_end": 34635805, "cds_start": 34614227, "n_exons": 8, "nonpsych": {"exp_lof": 12.2219325538, "exp_mis": 138.809694374, "exp_syn": 68.7003238337, "lof_z": 2.02878245249808, "mis_z": -1.29246618671549, "mu_lof": 9.26921119438e-07, "mu_mis": 1.34315915878e-05, "mu_syn": 6.51602132181e-06, "n_lof": 5.0, "n_mis": 169.0, "n_syn": 70.0, "p_li": 0.0172514048443311, "p_null": 0.027024114701824, "p_rec": 0.955724480453845, "syn_z": -0.0987235116689386}, "nontcga": {"exp_lof": 12.5729202249, "exp_mis": 141.245107295, "exp_syn": 69.9812986265, "lof_z": 1.8286118947864, "mis_z": -1.20541024710061, "mu_lof": 9.26921119438e-07, "mu_mis": 1.34315915878e-05, "mu_syn": 6.51602132181e-06, "n_lof": 6.0, "n_mis": 170.0, "n_syn": 70.0, "p_li": 0.00342344482549705, "p_null": 0.0451351624489117, "p_rec": 0.951441392725591, "syn_z": -0.00141537945851597}, "transcript": "ENST00000342136.4"}, "exons": [{"cdsend": 33262716, "cdsstart": 33241922, "chr": "21", "position": [[33229937, 33230216], [33241839, 33241977], [33243672, 33243714], [33244950, 33245074], [33246717, 33246890], [33248708, 33248854], [33252661, 33252830], [33260596, 33260727], [33262560, 33265663]], "strand": 1, "transcript": "NM_000874", "txend": 33265663, "txstart": 33229937}, {"cdsend": 33263500, "cdsstart": 33241922, "chr": "21", "position": [[33229937, 33230216], [33241839, 33241977], [33243672, 33243714], [33244950, 33245074], [33246717, 33246890], [33248708, 33248854], [33252661, 33252830], [33260596, 33260727], [33262792, 33265663]], "strand": 1, "transcript": "NM_001289125", "txend": 33265663, "txstart": 33229937}, {"cdsend": 33262803, "cdsstart": 33241922, "chr": "21", "position": [[33229894, 33230216], [33241885, 33241977], [33243672, 33243714], [33244950, 33245074], [33246717, 33246890], [33248708, 33248854], [33252661, 33252830], [33262792, 33264513]], "strand": 1, "transcript": "NM_001289126", "txend": 33264513, "txstart": 33229894}, {"cdsend": 33262803, "cdsstart": 33241922, "chr": "21", "position": [[33229894, 33230216], [33241839, 33241977], [33243672, 33243714], [33244950, 33245074], [33246717, 33246890], [33248708, 33248854], [33252661, 33252830], [33262792, 33264513]], "strand": 1, "transcript": "NM_001289128", "txend": 33264513, "txstart": 33229894}, {"cdsend": 33262577, "cdsstart": 33241922, "chr": "21", "position": [[33229937, 33230216], [33241885, 33241977], [33243672, 33243714], [33244950, 33245074], [33246717, 33246890], [33248708, 33248854], [33252661, 33252830], [33262560, 33265663]], "strand": 1, "transcript": "NM_001385054", "txend": 33265663, "txstart": 33229937}, {"cdsend": 33264971, "cdsstart": 33241922, "chr": "21", "position": [[33229937, 33230216], [33241885, 33241977], [33243672, 33243714], [33244950, 33245074], [33246717, 33246890], [33248708, 33248854], [33252661, 33252830], [33260596, 33260727], [33262792, 33263270], [33264933, 33265663]], "strand": 1, "transcript": "NM_001385055", "txend": 33265663, "txstart": 33229937}, {"cdsend": 33262716, "cdsstart": 33241922, "chr": "21", "position": [[33229937, 33230216], [33241885, 33241977], [33243672, 33243714], [33244950, 33245074], [33246717, 33246890], [33248708, 33248854], [33252661, 33252830], [33260596, 33260727], [33262560, 33265663]], "strand": 1, "transcript": "NM_207584", "txend": 33265663, "txstart": 33229937}, {"cdsend": 33263500, "cdsstart": 33241922, "chr": "21", "position": [[33229894, 33230216], [33241885, 33241977], [33243672, 33243714], [33244950, 33245074], [33246717, 33246890], [33248708, 33248854], [33252661, 33252830], [33260596, 33260727], [33262792, 33264513]], "strand": 1, "transcript": "NM_207585", "txend": 33264513, "txstart": 33229894}], "exons_hg19": [{"cdsend": 34635021, "cdsstart": 34614227, "chr": "21", "position": [[34602242, 34602521], [34614144, 34614282], [34615977, 34616019], [34617255, 34617379], [34619022, 34619195], [34621013, 34621159], [34624966, 34625135], [34632901, 34633032], [34634865, 34637968]], "strand": 1, "transcript": "NM_000874", "txend": 34637968, "txstart": 34602242}, {"cdsend": 34635805, "cdsstart": 34614227, "chr": "21", "position": [[34602242, 34602521], [34614144, 34614282], [34615977, 34616019], [34617255, 34617379], [34619022, 34619195], [34621013, 34621159], [34624966, 34625135], [34632901, 34633032], [34635097, 34637968]], "strand": 1, "transcript": "NM_001289125", "txend": 34637968, "txstart": 34602242}, {"cdsend": 34635108, "cdsstart": 34614227, "chr": "21", "position": [[34602199, 34602521], [34614190, 34614282], [34615977, 34616019], [34617255, 34617379], [34619022, 34619195], [34621013, 34621159], [34624966, 34625135], [34635097, 34636818]], "strand": 1, "transcript": "NM_001289126", "txend": 34636818, "txstart": 34602199}, {"cdsend": 34635108, "cdsstart": 34614227, "chr": "21", "position": [[34602199, 34602521], [34614144, 34614282], [34615977, 34616019], [34617255, 34617379], [34619022, 34619195], [34621013, 34621159], [34624966, 34625135], [34635097, 34636818]], "strand": 1, "transcript": "NM_001289128", "txend": 34636818, "txstart": 34602199}, {"cdsend": 34634882, "cdsstart": 34614227, "chr": "21", "position": [[34602242, 34602521], [34614190, 34614282], [34615977, 34616019], [34617255, 34617379], [34619022, 34619195], [34621013, 34621159], [34624966, 34625135], [34634865, 34637968]], "strand": 1, "transcript": "NM_001385054", "txend": 34637968, "txstart": 34602242}, {"cdsend": 34637276, "cdsstart": 34614227, "chr": "21", "position": [[34602242, 34602521], [34614190, 34614282], [34615977, 34616019], [34617255, 34617379], [34619022, 34619195], [34621013, 34621159], [34624966, 34625135], [34632901, 34633032], [34635097, 34635575], [34637238, 34637968]], "strand": 1, "transcript": "NM_001385055", "txend": 34637968, "txstart": 34602242}, {"cdsend": 34635021, "cdsstart": 34614227, "chr": "21", "position": [[34602242, 34602521], [34614190, 34614282], [34615977, 34616019], [34617255, 34617379], [34619022, 34619195], [34621013, 34621159], [34624966, 34625135], [34632901, 34633032], [34634865, 34637968]], "strand": 1, "transcript": "NM_207584", "txend": 34637968, "txstart": 34602242}, {"cdsend": 34635805, "cdsstart": 34614227, "chr": "21", "position": [[34602199, 34602521], [34614190, 34614282], [34615977, 34616019], [34617255, 34617379], [34619022, 34619195], [34621013, 34621159], [34624966, 34625135], [34632901, 34633032], [34635097, 34636818]], "strand": 1, "transcript": "NM_207585", "txend": 34636818, "txstart": 34602199}], "generif": [{"pubmed": 11786546, "text": "In this study we have characterized the Stat2-IFNaR2 interaction and examined its role in IFNalpha signaling"}, {"pubmed": 12105218, "text": "STAT3 activation by type I interferons is dependent on specific tyrosines located in the cytoplasmic domain of interferon receptor chain 2c"}, {"pubmed": 12218119, "text": "Expression and signaling activity of interferon alpha/beta receptors modulates dendritic cell (DC) responsiveness during terminal maturation and differentiation of monocyte-derived DCs."}, {"pubmed": 12220192, "text": "Subunit 2 of the interferon alpha receptor (IFNaR2) is bound more avidly to Stat2 than is phosphorylated IFNaR1."}, {"pubmed": 12618863, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 14647450, "text": "IFNAR1 and IFNAR2 levels reveal that the KAS-6/1 cell line overexpresses IFNAR1 relative to other myeloma cell lines that are growth arrested by IFN-alpha."}, {"pubmed": 14980076, "text": "Administration as a complex with sIFNAR-2 may provide a method of enhancing the delivery and effectiveness of type I interferons in Burkitt lymphoma in scid mice."}, {"pubmed": 15063762, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15286706, "text": "IFNaR2, a subunit of the type I IFN receptor, is proteolytically cleaved in a regulated manner."}, {"pubmed": 15287740, "text": "Dynamics of the IFNAR2 extracellular domain binding site reveal highly flexible loop segments and a malleable binding surface interacting with the IFN ligand supported by a more rigid scaffold which stabilizes the binding site conformation."}, {"pubmed": 15449939, "text": "A dynamic model for the IFN-alpha/receptor complex predicts that IFNAR2 and IFNAR1 are probably anchored in close proximity on the cell surface and that upon IFN binding, the complex assumes a closed form, resulting in activation of intracellular kinases."}, {"pubmed": 15717316, "text": "IFNaR2 intracellular domain transcriptional modulation is dependent upon the carboxyl-terminal transactivation domain of Stat2."}, {"pubmed": 15885318, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16054712, "text": "Rapid inhibition of MAPK signaling and anti-proliferation effect via JAK/STAT signaling by interferon-alpha in hepatocellular carcinoma cell lines."}, {"pubmed": 16106266, "text": "Oveexpression of IFNAR2 is associated with hepatocellular carcinoma"}, {"pubmed": 16518956, "text": "Hepatic IFNAR2c mRNA expression appears to correlate inversely with the fibrosis stage and age in hepatitis C infection."}, {"pubmed": 16624932, "text": "Monocyte-derived dendritic cells can modulate their sensitivity to two IFN subtypes by differential regulation of the IFNAR subunits."}, {"pubmed": 17095088, "text": "IFNAR2 cytoplasmic domain serves to link STAT4 to the IFNAR as a pre-assembled complex that facilitates cytokine-driven STAT4 activation."}, {"pubmed": 17517919, "text": "Data describe the species specificity of IFN-alphas, the residues in murine IFN-alpha4 that preclude strong affinity interactions with human IFNAR1 and 2, and residues in human IFN-alpha8 that resemble a receptor interactive domain in murine IFN-alpha4."}, {"pubmed": 17572016, "text": "binding of IFN-alpha8 rather than binding of IFN-alpha2 to IFNAR-2 leads to activation and subsequent antiproliferative activity despite the same antiviral activity in renal cell carcinoma"}, {"pubmed": 17667505, "text": "The intensity and distribution of IFNAR-2 may predict the response to therapy with IFN-alpha and IFN-beta in pancreatic cancer."}, {"pubmed": 17697365, "text": "High IFNAR2 is associated with renal cell carcinoma metastasis"}, {"pubmed": 17703412, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18027911, "text": "Results demonstrated that FNAR2-extracellular domain interact differentially with two individual IFN-alphas, suggesting the mutual interaction between multiple IFN-alpha subtypes during the competition for binding to the receptor."}, {"pubmed": 18338947, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18456457, "text": "The data suggest that liberation of the IFNaR2-ICD by regulated proteolysis could trigger a novel mechanism for moving the transcription factor Stat2 to the nucleus."}, {"pubmed": 18456658, "text": "The Stat3-activating Tyk2 V678F mutant does not up-regulate signaling through the type I interferon receptor but confers ligand hypersensitivity to a homodimeric receptor"}, {"pubmed": 18676680, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18715339, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18801736, "text": "the stability of the ternary interferon-receptor complex rather than the affinity to the individual subunits dictates differential biological activities"}, {"pubmed": 18971450, "text": "Findings show that interferon-alpha/beta receptor (IFNAR)-2 isoforms are important regulators of the responsiveness to endogenous and systemically administered interferon beta (IFNbeta)."}, {"pubmed": 19170196, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19258923, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19299650, "text": "Defective monocyte responses to IFNalpha/beta may play an important role in the pathogenesis of HIV-1 infection, and decreased IFNalpha/betaR expression may serve as a novel marker of disease progression."}, {"pubmed": 19362011, "text": "Results suggest that zinc, especially polaprezinc, enhances the expression of type 1 interferon 2 receptor in U937 cells, thereby inducing production of the anti-viral protein 2'-5'OAS."}, {"pubmed": 19401692, "text": "Ep-CAM is a potentially useful marker for resistance to INFalpha/5-FU therapy, especially in IFNAR2-positive cases."}, {"pubmed": 19434718, "text": "Clinical trial of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19453261, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19505916, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19625176, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19667218, "text": "Observational study and genome-wide association study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19692168, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19714778, "text": "The IFNAR2-8SS genotype was associated with HBeAg negative patients; IFNAR2-8F allele was associated with the risk to high viral loads; the IFNAR2-8FF genotype predisposed to higher MxA gene induction and correlated with sustained IFN response."}, {"pubmed": 19773279, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19773451, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 19796549, "text": "IFNAR1 (interferon-alpha receptor 1) (G/C in SNP18417) and IFNAR1 (interferon-alpha receptor 2) (G/T in SNP 11876) polymorphisms jointly, but not individually, may confer susceptibility to Behcets disease in a Turkish population"}, {"pubmed": 19796549, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 19817957, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20065083, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20087947, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 20237496, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20331378, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20453000, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20485444, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20503287, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20588308, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20811626, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 21690295, "text": "A low number of receptors suffices for antiviral response and is thus a robust feature common to all cells. Conversely, a high number of receptors is required for antiproliferative activity, which allows for fine-tuning on a single-cell level."}, {"pubmed": 22236545, "text": "IFNAR2 overexpression was observed in various histological types of lung cancer, and appears to be associated with lung cancers that behave aggressively."}, {"pubmed": 23663046, "text": "Results suggest that oxidative stress play an important role in the regulation of type I interferon receptors IFNAR1 and IFNAR2 in chronic hepatitis B virus (HBV) infection."}, {"pubmed": 23745570, "text": "The effects of two functional polymorphisms, type I interferon receptor 2 gene (IFNAR2)-F8S and interleukin-10 receptor subunit beta gene (IL10RB)-K47E, on chronic hepatitis B virus (HBV) infection, were investigated."}, {"pubmed": 24460759, "text": "Therefore, this study associated, for the first time, in a large panel of pancreatic cancer cell lines the effects of IFN-alpha/-beta with the expression of type-I IFN receptors."}, {"pubmed": 25072284, "text": "A very small percentage of the pancreatic tumors showed strong expression of the IFNAR-2c."}, {"pubmed": 25265476, "text": "The expression of IFNAR1, IFNgammaR1 and ribovarin transporters were significantly impaired in chronic liver disease and cirrhotic livers."}, {"pubmed": 26008745, "text": "Dimerization of IFNAR1 and IFNAR2 and the limiting role of IFNAR1 binding affinity in complex assembly is modulated by USP18."}, {"pubmed": 26176069, "text": "Lack of expression of functional IFNAR2 does not seem to be the major cause of interferon resistance in hepatitis C virus patients receiving standard interferon therapy."}, {"pubmed": 26679999, "text": "Data suggest IFNA2 (interferon, alpha 2) binding to extracellular domain of IFNAR1 or IFNAR2 promotes proximity between intracellular domains; signaling depends on duration of activation/affinity of binding rather than specific conformational changes."}, {"pubmed": 27346865, "text": "the level of IFNAR1, IFNAR2, and CCR5 mRNA expression was found to be significantly lower in the responders than nonresponders.Our results highlighted the significance of IFNAR and CCR5 genes in multiple sclerosis risk and the response to IFN-b therapy."}, {"pubmed": 27613121, "text": "Report lowered serum IFNAR2 levels in multiple sclerosis patients are elevated on treatment with interferon-beta."}, {"pubmed": 27891600, "text": "this study shows that the surface expression levels of the common IFN-alpha/beta receptor subunit 2 are significantly higher on plasmacytoid dendritic cells from females in comparison to males"}, {"pubmed": 29080269, "text": "Significant associations were observed for 4 variants in IFNAR2, IFNLR1 with hepatitis B virus infection, and IFNLR1-rs4649203 was associated with hepatitis B recovery. Moreover, the authors demonstrated the clear relevance of 5 polymorphisms in IFNA1, IFNA2, IFNL4 with hepatocellular carcinoma."}, {"pubmed": 29997210, "text": "The findings underline the roles of UL36USP-IFNAR2 interaction in counteracting the type I IFN-mediated signaling pathway and reveal a novel evasion mechanism of antiviral innate immunity by HSV-1."}, {"pubmed": 30920934, "text": "S27 of IFNalpha1 Contributes to Its Low Affinity for IFNAR2 and Weak Antiviral Activity"}, {"pubmed": 31705658, "text": "Respirovirus C protein inhibits activation of type I interferon receptor-associated kinases to block JAK-STAT signaling."}, {"pubmed": 31935222, "text": "Our data suggests that potential changes in the IFN responsiveness of mucosal immune cells during HIV infection are unlikely dictated by changes in IFNAR2 expression."}, {"pubmed": 33552080, "text": "Interferon Receptor Trafficking and Signaling: Journey to the Cross Roads."}, {"pubmed": 33949668, "text": "Integrative genomics analysis reveals a 21q22.11 locus contributing risk to COVID-19."}, {"pubmed": 34355676, "text": "Deleterious single nucleotide polymorphisms (SNPs) of human IFNAR2 gene facilitate COVID-19 severity in patients: a comprehensive in silico approach."}, {"pubmed": 34813358, "text": "IFNAR1 and IFNAR2 play distinct roles in initiating type I interferon-induced JAK-STAT signaling and activating STATs."}, {"pubmed": 34975865, "text": "Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment."}, {"pubmed": 35081872, "text": "Long non-coding RNA prostate cancer-associated transcript 6 inhibited gefitinib sensitivity of non-small cell lung cancer by serving as a competing endogenous RNA of miR-326 to up-regulate interferon-alpha receptor 2."}, {"pubmed": 35442417, "text": "Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic."}, {"pubmed": 35967349, "text": "IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19."}, {"pubmed": 36439115, "text": "Type I interferon receptor (IFNAR2) deficiency reveals Zika virus cytopathicity in human macrophages and microglia."}, {"pubmed": 36672770, "text": "Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 Genes Are Associated with Worse Clinical Outcomes in COVID-19."}, {"pubmed": 36927455, "text": "Polymorphism in interferon alpha/beta receptor contributes to glucocorticoid response and outcome of ARDS and COVID-19."}, {"pubmed": 37028439, "text": "Association of IFNAR1 and IFNAR2 with COVID-19 severity."}, {"pubmed": 38760017, "text": "TYK2, IFITM3, IFNAR2 and OAS3 single-nucleotide polymorphisms among severe COVID-19 ICU patients in Morocco."}], "genomic_pos": {"chr": "21", "end": 33265675, "ensemblgene": "ENSG00000159110", "start": 33205282, "strand": 1}, "genomic_pos_hg19": {"chr": "21", "end": 34637980, "start": 34602206, "strand": 1}, "go": {"BP": [{"evidence": "TAS", "gocategory": "BP", "id": "GO:0007166", "pubmed": 8798579, "qualifier": "involved_in", "term": "cell surface receptor signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0007259", "pubmed": [7759950, 10556041], "qualifier": "involved_in", "term": "cell surface receptor signaling pathway via JAK-STAT"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0009615", "pubmed": 7588638, "qualifier": "involved_in", "term": "response to virus"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035455", "pubmed": 7759950, "qualifier": "involved_in", "term": "response to interferon-alpha"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0035455", "pubmed": 26424569, "qualifier": "involved_in", "term": "response to interferon-alpha"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035456", "pubmed": 7759950, "qualifier": "involved_in", "term": "response to interferon-beta"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0035456", "pubmed": 26424569, "qualifier": "involved_in", "term": "response to interferon-beta"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035458", "pubmed": 7759950, "qualifier": "involved_in", "term": "cellular response to interferon-beta"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0046425", "qualifier": "involved_in", "term": "regulation of receptor signaling pathway via JAK-STAT"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0051607", "pubmed": 26424569, "qualifier": "involved_in", "term": "defense response to virus"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0060337", "qualifier": "involved_in", "term": "type I interferon-mediated signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0060337", "pubmed": [7665574, 21854986], "qualifier": "involved_in", "term": "type I interferon-mediated signaling pathway"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0060337", "pubmed": 26424569, "qualifier": "involved_in", "term": "type I interferon-mediated signaling pathway"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0060337", "pubmed": 30936491, "qualifier": "involved_in", "term": "type I interferon-mediated signaling pathway"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0098586", "pubmed": 30936491, "qualifier": "involved_in", "term": "cellular response to virus"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0140865", "qualifier": "involved_in", "term": "interleukin-22-mediated signaling pathway"}], "CC": [{"evidence": "IEA", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "pubmed": 7759950, "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0004905", "qualifier": "enables", "term": "type I interferon receptor activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004905", "pubmed": [7665574, 7759950, 10556041, 21854986], "qualifier": "enables", "term": "type I interferon receptor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [7665574, 9121453, 11046044, 16710296, 17923090, 21854986, 28165510], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0008269", "pubmed": 34813358, "qualifier": "enables", "term": "JAK pathway signal transduction adaptor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0019901", "pubmed": 7759950, "qualifier": "enables", "term": "protein kinase binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0019955", "pubmed": [8798579, 8969169], "qualifier": "enables", "term": "cytokine binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0042018", "qualifier": "enables", "term": "interleukin-22 receptor activity"}]}, "homologene": {"genes": [[9031, 395664], [9544, 699726], [9598, 473965], [9606, 3455], [9615, 100856468], [9913, 282258], [10090, 15976], [10116, 686326]], "id": 49242}, "interpro": [{"desc": "Fibronectin type III", "id": "IPR003961", "short_desc": "FN3_dom"}, {"desc": "Immunoglobulin-like fold", "id": "IPR013783", "short_desc": "Ig-like_fold"}, {"desc": "Fibronectin type III superfamily", "id": "IPR036116", "short_desc": "FN3_sf"}, {"desc": "Interferon/interleukin receptor domain", "id": "IPR015373", "short_desc": "Interferon/interleukin_rcp_dom"}], "ipi": ["IPI00010193", "IPI00220690", "IPI00220691", "IPI00853210", "IPI00893042", "IPI00924877", "IPI00925121"], "map_location": "21q22.11", "name": "interferon alpha and beta receptor subunit 2", "other_names": ["IFN-alpha/beta receptor 2", "IFNalpha/beta receptor subunit 2", "human interferon alpha/beta receptor", "interferon (alpha, beta and omega) receptor 2", "interferon alpha binding protein", "interferon alpha/beta receptor 2", "interferon receptor", "interferon-alpha/beta receptor beta chain", "type I interferon receptor 2"], "pantherdb": {"HGNC": "5433", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1098243", "ortholog_type": "LDO", "panther_family": "PTHR20859", "taxid": 10090, "uniprot_kb": "O35664"}, {"RGD": "1583177", "ortholog_type": "LDO", "panther_family": "PTHR20859", "taxid": 10116, "uniprot_kb": "M0R8H7"}, {"Ensembl": "ENSGALG00000041867", "ortholog_type": "O", "panther_family": "PTHR20859", "taxid": 9031, "uniprot_kb": "A0A1D5P3K6"}, {"Ensembl": "ENSGALG00000049755", "ortholog_type": "O", "panther_family": "PTHR20859", "taxid": 9031, "uniprot_kb": "A0A3Q2UAP1"}, {"ZFIN": "ZDB-GENE-081022-158", "ortholog_type": "O", "panther_family": "PTHR20859", "taxid": 7955, "uniprot_kb": "F6NZK1"}, {"ZFIN": "ZDB-GENE-060421-4184", "ortholog_type": "O", "panther_family": "PTHR20859", "taxid": 7955, "uniprot_kb": "Q1RM05"}, {"ZFIN": "ZDB-GENE-070905-2", "ortholog_type": "O", "panther_family": "PTHR20859", "taxid": 7955, "uniprot_kb": "B0UXH1"}, {"ZFIN": "ZDB-GENE-030131-5999", "ortholog_type": "O", "panther_family": "PTHR20859", "taxid": 7955, "uniprot_kb": "B0S5R4"}, {"ZFIN": "ZDB-GENE-071120-8", "ortholog_type": "O", "panther_family": "PTHR20859", "taxid": 7955, "uniprot_kb": "F1Q9C5"}, {"ZFIN": "ZDB-GENE-070905-4", "ortholog_type": "O", "panther_family": "PTHR20859", "taxid": 7955, "uniprot_kb": "A0A0R4ITC2"}, {"ZFIN": "ZDB-GENE-071120-6", "ortholog_type": "O", "panther_family": "PTHR20859", "taxid": 7955, "uniprot_kb": "A0A0R4IAL7"}, {"ZFIN": "ZDB-GENE-160728-134", "ortholog_type": "O", "panther_family": "PTHR20859", "taxid": 7955, "uniprot_kb": "A0A1D5NSZ8"}, {"ZFIN": "ZDB-GENE-071120-5", "ortholog_type": "O", "panther_family": "PTHR20859", "taxid": 7955, "uniprot_kb": "E7F976"}, {"ZFIN": "ZDB-GENE-060512-349", "ortholog_type": "O", "panther_family": "PTHR20859", "taxid": 7955, "uniprot_kb": "B8A6I7"}], "uniprot_kb": "P48551"}, "pathway": {"biocarta": [{"id": "ifnapathway", "name": "ifn alpha signaling pathway"}, {"id": "ranklpathway", "name": "bone remodeling"}], "kegg": [{"id": "hsa04060", "name": "Cytokine-cytokine receptor interaction - Homo sapiens (human)"}, {"id": "hsa04151", "name": "PI3K-Akt signaling pathway - Homo sapiens (human)"}, {"id": "hsa04217", "name": "Necroptosis - Homo sapiens (human)"}, {"id": "hsa04380", "name": "Osteoclast differentiation - Homo sapiens (human)"}, {"id": "hsa04620", "name": "Toll-like receptor signaling pathway - Homo sapiens (human)"}, {"id": "hsa04621", "name": "NOD-like receptor signaling pathway - Homo sapiens (human)"}, {"id": "hsa04630", "name": "JAK-STAT signaling pathway - Homo sapiens (human)"}, {"id": "hsa04650", "name": "Natural killer cell mediated cytotoxicity - Homo sapiens (human)"}, {"id": "hsa05160", "name": "Hepatitis C - Homo sapiens (human)"}, {"id": "hsa05162", "name": "Measles - Homo sapiens (human)"}, {"id": "hsa05164", "name": "Influenza A - Homo sapiens (human)"}, {"id": "hsa05165", "name": "Human papillomavirus infection - Homo sapiens (human)"}, {"id": "hsa05167", "name": "Kaposi sarcoma-associated herpesvirus infection - Homo sapiens (human)"}, {"id": "hsa05168", "name": "Herpes simplex virus 1 infection - Homo sapiens (human)"}, {"id": "hsa05169", "name": "Epstein-Barr virus infection - Homo sapiens (human)"}, {"id": "hsa05171", "name": "Coronavirus disease - COVID-19 - Homo sapiens (human)"}, {"id": "hsa05200", "name": "Pathways in cancer - Homo sapiens (human)"}], "pid": [{"id": "cd8tcrdownstreampathway", "name": "Downstream signaling in na&#xef;ve CD8+ T cells"}, {"id": "telomerasepathway", "name": "Regulation of Telomerase"}], "reactome": [{"id": "R-HSA-1280215", "name": "Cytokine Signaling in Immune system"}, {"id": "R-HSA-1280215", "name": "Cytokine Signaling in Immune system"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-5663205", "name": "Infectious disease"}, {"id": "R-HSA-909733", "name": "Interferon alpha/beta signaling"}, {"id": "R-HSA-909733", "name": "Interferon alpha/beta signaling"}, {"id": "R-HSA-912694", "name": "Regulation of IFNA/IFNB signaling"}, {"id": "R-HSA-912694", "name": "Regulation of IFNA/IFNB signaling"}, {"id": "R-HSA-913531", "name": "Interferon Signaling"}, {"id": "R-HSA-913531", "name": "Interferon Signaling"}, {"id": "R-HSA-9679191", "name": "Potential therapeutics for SARS"}, {"id": "R-HSA-9679506", "name": "SARS-CoV Infections"}, {"id": "R-HSA-9694516", "name": "SARS-CoV-2 Infection"}, {"id": "R-HSA-9705671", "name": "SARS-CoV-2 activates/modulates innate and adaptive immune responses"}, {"id": "R-HSA-9705683", "name": "SARS-CoV-2-host interactions"}, {"id": "R-HSA-9820952", "name": "Respiratory Syncytial Virus Infection Pathway"}, {"id": "R-HSA-9824446", "name": "Viral Infection Pathways"}, {"id": "R-HSA-9833109", "name": "Evasion by RSV of host interferon responses"}, {"id": "R-HSA-9833110", "name": "RSV-host interactions"}], "wikipathways": [{"id": "WP1449", "name": "Regulation of toll-like receptor signaling pathway"}, {"id": "WP3932", "name": "Focal Adhesion-PI3K-Akt-mTOR-signaling pathway"}, {"id": "WP4172", "name": "PI3K-Akt signaling pathway"}, {"id": "WP4197", "name": "Immune response to tuberculosis"}, {"id": "WP4538", "name": "Regulatory circuits of the STAT3 signaling pathway"}, {"id": "WP4558", "name": "Overview of interferons-mediated signaling pathway"}, {"id": "WP4868", "name": "Type I interferon induction and signaling during SARS-CoV-2 infection"}, {"id": "WP4880", "name": "Host-pathogen interaction of human coronaviruses - interferon induction"}, {"id": "WP4912", "name": "SARS coronavirus and innate immunity"}, {"id": "WP5039", "name": "SARS-CoV-2 innate immunity evasion and cell-specific immune response"}, {"id": "WP585", "name": "Interferon type I signaling pathways"}, {"id": "WP75", "name": "Toll-like Receptor Signaling Pathway"}]}, "pdb": ["1N6U", "1N6V", "2HYM", "2KZ1", "2LAG", "3S8W", "3S9D", "3SE3", "3SE4"], "pfam": ["PF01108", "PF09294"], "pharmgkb": "PA29671", "pharos": {"target_id": 8113, "tdl": "Tclin"}, "pir": ["A54295", "I39073", "S59501"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF251183", "relationship": "is"}, {"id": "GNF251184", "relationship": "is"}, {"id": "GNF251185", "relationship": "is"}, {"id": "GNF251186", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF161831", "relationship": "is"}, "GNF_hs-Origene": {"id": "GNF037835", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF084878", "relationship": "is"}, {"id": "GNF084879", "relationship": "is"}, {"id": "GNF084880", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF054623", "relationship": "is"}, {"id": "GNF059401", "relationship": "is"}, {"id": "GNF074784", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF068319", "relationship": "is"}, {"id": "GNF068320", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF006945", "relationship": "is"}, "GNF_mm+hs_RetroCDNA": {"id": "GNF285660", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF096949", "relationship": "is"}, {"id": "GNF136604", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000021.9", "NC_060945.1", "NG_016003.2"], "protein": ["NP_000865.2", "NP_001276054.1", "NP_001276055.1", "NP_001276057.1", "NP_001371983.1", "NP_001371984.1", "NP_997467.1", "NP_997468.1"], "rna": ["NM_000874.5", "NM_001289125.3", "NM_001289126.2", "NM_001289128.2", "NM_001385054.1", "NM_001385055.1", "NM_207584.3", "NM_207585.3"], "translation": [{"protein": "NP_001371984.1", "rna": "NM_001385055.1"}, {"protein": "NP_001371983.1", "rna": "NM_001385054.1"}, {"protein": "NP_997467.1", "rna": "NM_207584.3"}, {"protein": "NP_001276055.1", "rna": "NM_001289126.2"}, {"protein": "NP_997468.1", "rna": "NM_207585.3"}, {"protein": "NP_001276054.1", "rna": "NM_001289125.3"}, {"protein": "NP_000865.2", "rna": "NM_000874.5"}, {"protein": "NP_001276057.1", "rna": "NM_001289128.2"}]}, "reporter": {"HG-U133_Plus_2": ["204785_x_at", "204786_s_at", "227125_at"], "HG-U95Av2": ["1568_s_at", "1588_at", "1589_s_at"], "HTA-2_0": "TC21001060.hg.1", "HuEx-1_0": ["3918447", "3918533"], "HuGene-1_1": "8068238", "HuGene-2_1": "16922222"}, "summary": "The protein encoded by this gene is a type I membrane protein that forms one of the two chains of a receptor for interferons alpha and beta. Binding and activation of the receptor stimulates Janus protein kinases, which in turn phosphorylate several proteins, including STAT1 and STAT2. The protein belongs to the type II cytokine receptor family. Mutations in this gene are associated with Immunodeficiency 45. [provided by RefSeq, Jul 2020].", "symbol": "IFNAR2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1334082"}, "unigene": "Hs.708195", "uniprot": {"Swiss-Prot": "P48551", "TrEMBL": ["F8WDE1", "Q9BUA0", "C9JM33", "C9JCU0", "C9K067", "H7C176", "A0A804HLE8"]}, "wikipedia": {"url_stub": "IFNAR2"}}